{
  "specialty": "Psychiatry",
  "condition": "bipolar_disorder",
  "template_name": "psychiatry_bipolar_disorder",
  "sections": [
    {
      "My Clinical Question (condition: Bipolar)": "***"
    },
    {
      "My most current assessment of this problem can be found in the note dated": "{Today/***}"
    },
    {
      "In your clinical question, or current note, please include information on": {
        "Assessments": [
          {
            "Onset, duration and timing of symptoms": "***"
          },
          {
            "Co-morbid conditions (insomnia, substance use include tobacco and caffeine, OSA, hyper/hypothyroidism, neurological disorders)": "***"
          },
          {
            "Any current/historical psychiatric medications": "***"
          },
          {
            "Any current psychiatric providers/therapists?": "***"
          }
        ],
        "Diagnostics": [
          {
            "PHQ9 if patient is in depressive state": "***"
          },
          {
            "Lithium, lamotrigine,valproic acid, or carbemazapine levels (if on these medications)": "***"
          },
          {
            "Lipid and fasting glucose/HA1c (if on an antipsychotic)": "***"
          },
          {
            "CBC, CMP, TSH with reflex to T4": "***"
          }
        ],
        "Clinical Pearls": [
          {
            "Patients on lithium should have regular thyroid screening as well as monitoring of kidney function": "***"
          },
          {
            "Patients on depakote should have regular LFT monitoring as well as CBC monitoring (can cause thrombocytopenia)": "***"
          },
          {
            "Depakote, carbemazapine, and lamotrigine all interact with OCPs and are also associated with neural tube defects in pregnancy, special caution when using these in women on OCPs or planning pregnancy": "***"
          }
        ]
      }
    }
  ]
}